Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PAHC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 -0.793M
December 31, 2018 -0.13M
September 30, 2018 -0.211M
June 30, 2018 -0.407M
March 31, 2018 -1.592M
December 31, 2017 -0.214M
September 30, 2017 -3.486M
June 30, 2017 -2.961M
March 31, 2017 -2.47M
December 31, 2016 -0.11M
September 30, 2016 0.00
June 30, 2016 -0.052M
March 31, 2016 -1.887M
December 31, 2015 -1.385M
September 30, 2015 -0.693M
June 30, 2015 -0.718M
March 31, 2015 -0.458M
December 31, 2014 -0.158M
September 30, 2014 0.00
June 30, 2014 -114.43M
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 584.00M
Merck & Co., Inc. 714.00M
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M
Veru, Inc. -0.001M